Certara is dedicated to improving human health by offering a broad spectrum of software products and services, with special focus on supporting translational approaches to drug development.
Access, visualize, and analyze drug discovery, pre-clinical and clinical data.
Certara’s molecular modeling and simulation software supports predictive science for drug discovery and other life sciences.
Conduct simulations in virtual patient populations based on in vitro and clinical data.
Phoenix is the premier PK/PD modeling and simulation software platform for managing, analyzing and reporting preclinical and clinical data.
Minimize risks and guide decision making for drug trials.
Assess cardiac safety risks in drug candidates.
Support your strategic drug development decisions and new drug approvals through quantitative analysis and predictive models of diseases, drugs and clinical trials.
Consultancy and guidance on a broad spectrum of DMPK issues, including optimal design for metabolic drug-drug interaction studies, interpretation of data and prediction of in vivo ADME from in vitro studies.
Multi-disciplinary expert scientific team with expertise in pharmacometrics, PK analysis and programming, biostatistics, and medical writing.
Our team of scientists has supported over 50 recent drug approvals, labels, and submissions through biosimulation
Find papers, presentations, & webinars about scientific informatics, PK/PD modeling & simulation, PBPK modeling & simulation, and molecular modeling.
Access to some of our resources requires a registered account and "Log
In" is required.
Certara's scientific consultants support strategic drug development decisions and submission-ready analyses.
Site Map | Careers | Contact Us | Legal
Certara, L.P., All rights reserved.
Certara USA, Inc.
100 Overlook Center, Suite 101
Princeton, NJ 08540 USA